VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Humancomplement cascade modification by exogenious heparin

   
Galebskaya L.V.1, Solovtzova I.L.1, Ryumina E.V.1

1. Saint-Petersburg State Pavlov Medical University
PubMed Id: 11386002
Year: 2001  Volume: 47  Issue: 1  Pages: 91-97
The influence of heparin therapeutic concentrations (0.25-10 U/ml) on the kinetic indices of human serum complement activity has been studied. An acceleration of complement-dependent lysis of rabbit erythrocytes via alternative complement pathway was found at low (0.25-0.5 U/ml) heparin concentrations and complement inhibition at higher (5-10 U/ml) concentration. The alternative pathway inhibition was revealed mainly by lag-period elongation of the hemolysis. Heparin in the concentrations more then 1 U/ml caused dose-dependent lowering of sheep erythrocytes hemolysis rate accompanied with reciprocal elevation of complement hemolytical capacity, which shows more "economical" consumption of complement components at heparin presence. The identical effect was observed in sera, deficient in factor D of alternative pathway of complement activation. This can be an evidence of the prevailing heparin inhibition of the classical pathway.
Download PDF:  
Citation:

Galebskaya, L. V., Solovtzova, I. L., Ryumina, E. V. (2001). Humancomplement cascade modification by exogenious heparin. Voprosy Meditsinskoi Khimii, 47(1), 91-97.
References
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)
◄        ►